258 related articles for article (PubMed ID: 27253998)
21. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.
Joseph B; Ji M; Liu D; Hou P; Xing M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173
[TBL] [Abstract][Full Text] [Related]
22. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone.
Fugier C; Tousaint JJ; Prieur X; Plateroti M; Samarut J; Delerive P
J Biol Chem; 2006 Apr; 281(17):11553-9. PubMed ID: 16505486
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
24. Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression.
Weinhofer I; Kunze M; Rampler H; Forss-Petter S; Samarut J; Plateroti M; Berger J
Eur J Cell Biol; 2008 Dec; 87(12):933-45. PubMed ID: 18834645
[TBL] [Abstract][Full Text] [Related]
25. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
[TBL] [Abstract][Full Text] [Related]
26. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
[TBL] [Abstract][Full Text] [Related]
27. Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells.
Tandon M; Gokul K; Ali SA; Chen Z; Lian J; Stein GS; Pratap J
Mol Cancer; 2012 Jun; 11():27. PubMed ID: 22537242
[TBL] [Abstract][Full Text] [Related]
28. Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.
López-Mateo I; Alonso-Merino E; Suarez-Cabrera C; Park JW; Cheng SY; Alemany S; Paramio JM; Aranda A
Thyroid; 2020 Jan; 30(1):116-132. PubMed ID: 31760908
[No Abstract] [Full Text] [Related]
29. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY
Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445
[TBL] [Abstract][Full Text] [Related]
30. Both thyroid hormone receptor (TR)beta 1 and TR beta 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone.
Dupré SM; Guissouma H; Flamant F; Seugnet I; Scanlan TS; Baxter JD; Samarut J; Demeneix BA; Becker N
Endocrinology; 2004 May; 145(5):2337-45. PubMed ID: 14726446
[TBL] [Abstract][Full Text] [Related]
31. Novel oncogenic actions of TRbeta mutants in tumorigenesis.
Guigon CJ; Cheng SY
IUBMB Life; 2009 May; 61(5):528-36. PubMed ID: 19391168
[TBL] [Abstract][Full Text] [Related]
32. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
33. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.
Ying H; Furuya F; Zhao L; Araki O; West BL; Hanover JA; Willingham MC; Cheng SY
J Clin Invest; 2006 Nov; 116(11):2972-84. PubMed ID: 17039256
[TBL] [Abstract][Full Text] [Related]
34. Stanniocalcin 1 induction by thyroid hormone depends on thyroid hormone receptor β and phosphatidylinositol 3-kinase activation.
Moeller LC; Haselhorst NE; Dumitrescu AM; Cao X; Seo H; Refetoff S; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):81-5. PubMed ID: 20827662
[TBL] [Abstract][Full Text] [Related]
35. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells.
Endo T; Ohta K; Kobayashi T
J Clin Endocrinol Metab; 2008 Jun; 93(6):2409-12. PubMed ID: 18381576
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of Runt-Related Transcription Factor-2 Through CCAAT Enhancer Binding Protein-β Signaling Pathway in Microglial BV-2 Cells Exposed to ATP.
Nakazato R; Takarada T; Ikeno S; Nakamura S; Kutsukake T; Hinoi E; Yoneda Y
J Cell Physiol; 2015 Oct; 230(10):2510-21. PubMed ID: 25802132
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone induces hypoxia-inducible factor 1alpha gene expression through thyroid hormone receptor beta/retinoid x receptor alpha-dependent activation of hepatic leukemia factor.
Otto T; Fandrey J
Endocrinology; 2008 May; 149(5):2241-50. PubMed ID: 18239067
[TBL] [Abstract][Full Text] [Related]
40. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
